US 9273143
Methods and compositions comprising a combination of an anti-ErbB3 antibody and an anti-EGFR antibody
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9273143 (Methods and compositions comprising a combination of an anti-ErbB3 antibody and an anti-EGFR antibody) held by REGENERON PHARMACEUTICALS, INC. expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2039/505, A61K2039/507